{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:54:49Z","timestamp":1776873289698,"version":"3.51.2"},"reference-count":43,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572560"],"award-info":[{"award-number":["81572560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Shenkang Hospital Development Center","award":["16CR2012A"],"award-info":[{"award-number":["16CR2012A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/carcin\/bgz078","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:12:54Z","timestamp":1555528374000},"source":"Crossref","is-referenced-by-count":8,"title":["SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination"],"prefix":"10.1093","author":[{"given":"Liwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-6196","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"2019052310200285300_CIT0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA. Cancer J. Clin."},{"key":"2019052310200285300_CIT0002","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"2019052310200285300_CIT0003","first-page":"1","article-title":"SET and MYND domain containing protein 3 in cancer","volume":"9","author":"Lei","year":"2017","journal-title":"Am. J. Transl. Res"},{"key":"2019052310200285300_CIT0004","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2016.08.008","article-title":"Smyd3-associated regulatory pathways in cancer","volume":"42","author":"Giakountis","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"2019052310200285300_CIT0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncb1151","article-title":"SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells","volume":"6","author":"Hamamoto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"2019052310200285300_CIT0006","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1158\/0008-5472.CAN-16-0500","article-title":"SMYD3-mediated H2A.Z.1 methylation promotes cell cycle and cancer proliferation","volume":"76","author":"Tsai","year":"2016","journal-title":"Cancer Res."},{"key":"2019052310200285300_CIT0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2013.10.026","article-title":"Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells","volume":"344","author":"Luo","year":"2014","journal-title":"Cancer Lett."},{"key":"2019052310200285300_CIT0008","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/nar\/gkx1259","article-title":"The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells","volume":"46","author":"Zhang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2019052310200285300_CIT0009","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4161\/epi.19506","article-title":"Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation","volume":"7","author":"Van Aller","year":"2012","journal-title":"Epigenetics"},{"key":"2019052310200285300_CIT0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/0008-5472.CAN-11-1052","article-title":"SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9","volume":"72","author":"Cock-Rada","year":"2012","journal-title":"Cancer Res."},{"key":"2019052310200285300_CIT0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature13320","article-title":"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer","volume":"510","author":"Mazur","year":"2014","journal-title":"Nature"},{"key":"2019052310200285300_CIT0012","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1158\/0008-5472.CAN-07-1132","article-title":"The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3","volume":"67","author":"Kunizaki","year":"2007","journal-title":"Cancer Res."},{"key":"2019052310200285300_CIT0013","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.str.2016.03.010","article-title":"Structure-based design of a novel SMYD3 inhibitor that bridges the SAM-and MEKK2-binding pockets","volume":"24","author":"Van Aller","year":"2016","journal-title":"Structure"},{"key":"2019052310200285300_CIT0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.10.043","article-title":"A global map of p53 transcription-factor binding sites in the human genome","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"key":"2019052310200285300_CIT0015","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/onc.2009.154","article-title":"XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway","volume":"28","author":"Tanikawa","year":"2009","journal-title":"Oncogene"},{"key":"2019052310200285300_CIT0016","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.4161\/cc.10.24.18552","article-title":"miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions","volume":"10","author":"Siemens","year":"2011","journal-title":"Cell Cycle"},{"key":"2019052310200285300_CIT0017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ncb1875","article-title":"p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug","volume":"11","author":"Wang","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"2019052310200285300_CIT0018","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1128\/MCB.17.11.6330","article-title":"Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter","volume":"17","author":"Bian","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"2019052310200285300_CIT0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/2159-8290.CD-13-0136","article-title":"Contribution of p53 to metastasis","volume":"4","author":"Powell","year":"2014","journal-title":"Cancer Discov."},{"key":"2019052310200285300_CIT0020","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1093\/nar\/gku501","article-title":"Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters","volume":"42","author":"Loughery","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2019052310200285300_CIT0021","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"2019052310200285300_CIT0022","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/35023500","article-title":"An intact HDM2 RING-finger domain is required for nuclear exclusion of p53","volume":"2","author":"Boyd","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"2019052310200285300_CIT0023","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1093\/emboj\/18.22.6462","article-title":"Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1","volume":"18","author":"Gostissa","year":"1999","journal-title":"EMBO J."},{"key":"2019052310200285300_CIT0024","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.molcel.2007.07.012","article-title":"Modulation of p53 function by SET8-mediated methylation at lysine 382","volume":"27","author":"Shi","year":"2007","journal-title":"Mol. Cell"},{"key":"2019052310200285300_CIT0025","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1038\/ncomms5735","article-title":"ArhGAP30 promotes p53 acetylation and function in colorectal cancer","volume":"5","author":"Wang","year":"2014","journal-title":"Nat. Commun."},{"key":"2019052310200285300_CIT0026","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2007.15.6521","article-title":"High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma","volume":"26","author":"Zhu","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"2019052310200285300_CIT0027","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/onc.2015.197","article-title":"p54(nrb)\/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A","volume":"35","author":"Zhu","year":"2016","journal-title":"Oncogene"},{"key":"2019052310200285300_CIT0028","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"2019052310200285300_CIT0029","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1038\/onc.2017.196","article-title":"GATA3 interacts with and stabilizes HIF-1\u03b1 to enhance cancer cell invasiveness","volume":"36","author":"Lin","year":"2017","journal-title":"Oncogene"},{"key":"2019052310200285300_CIT0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.26398","article-title":"PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1\u03b1 expression and protein stability","volume":"58","author":"Liu","year":"2013","journal-title":"Hepatology"},{"key":"2019052310200285300_CIT0031","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1093\/nar\/gkr019","article-title":"Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding","volume":"39","author":"Xu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"2019052310200285300_CIT0032","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1038\/ncomms6059","article-title":"ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"key":"2019052310200285300_CIT0033","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2019052310200285300_CIT0034","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/35023507","article-title":"The MDM2 RING-finger domain is required to promote p53 nuclear export","volume":"2","author":"Geyer","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"2019052310200285300_CIT0035","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1128\/MCB.20.22.8458-8467.2000","article-title":"Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation","volume":"20","author":"Rodriguez","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2019052310200285300_CIT0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","article-title":"Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity","volume":"118","author":"Xirodimas","year":"2004","journal-title":"Cell"},{"key":"2019052310200285300_CIT0037","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Brooks","year":"2006","journal-title":"Mol. Cell"},{"key":"2019052310200285300_CIT0038","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nature05902","article-title":"Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging","volume":"447","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"2019052310200285300_CIT0039","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.12659\/MSM.898095","article-title":"SET and MYND domain-containing protein 3 (SMYD3) polymorphism as a risk factor for susceptibility and poor prognosis in ovarian cancer","volume":"22","author":"Liu","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"2019052310200285300_CIT0040","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/jcp.24975","article-title":"A SMYD3 small-molecule inhibitor impairing cancer cell growth","volume":"230","author":"Peserico","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"2019052310200285300_CIT0041","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature03117","article-title":"Regulation of p53 activity through lysine methylation","volume":"432","author":"Chuikov","year":"2004","journal-title":"Nature"},{"key":"2019052310200285300_CIT0042","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature05287","article-title":"Repression of p53 activity by Smyd2-mediated methylation","volume":"444","author":"Huang","year":"2006","journal-title":"Nature"},{"key":"2019052310200285300_CIT0043","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature06092","article-title":"p53 is regulated by the lysine demethylase LSD1","volume":"449","author":"Huang","year":"2007","journal-title":"Nature"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgz078\/28697853\/bgz078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:20:39Z","timestamp":1558621239000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article\/doi\/10.1093\/carcin\/bgz078\/5475274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgz078","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"article-number":"bgz078"}}